Nightingale Health Plc – Managers’ transactions – Timo Soininen
Managers' transactions Mar 30, 2021
Nightingale Health Plc – Managers’ transactions – 30 March 2021 9:30 a.m. (Finnish time)
Nightingale Health Plc – Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Soininen, Timo
Position: Member of the Board/Deputy member
Issuer: Nightingale Health Oyj
LEI: 743700WUIPC24LVMLO66
Notification type: INITIAL NOTIFICATION
Reference number: 743700WUIPC24LVMLO66_20210330085027_2
____________________________________________
Transaction date: 2021-03-29
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000490875
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 500 Unit price: 5.18 EUR
(2): Volume: 500 Unit price: 5.18 EUR
(3): Volume: 460 Unit price: 5.18 EUR
(4): Volume: 355 Unit price: 5.18 EUR
(5): Volume: 385 Unit price: 5.18 EUR
(6): Volume: 615 Unit price: 5.18 EUR
(7): Volume: 924 Unit price: 5.18 EUR
(8): Volume: 133 Unit price: 5.16 EUR
(9): Volume: 653 Unit price: 5.18 EUR
(10): Volume: 203 Unit price: 5.18 EUR
(11): Volume: 323 Unit price: 5.18 EUR
(12): Volume: 1,474 Unit price: 5.18 EUR
(13): Volume: 130 Unit price: 5.12 EUR
(14): Volume: 228 Unit price: 5.1 EUR
(15): Volume: 273 Unit price: 5.16 EUR
(16): Volume: 582 Unit price: 5.16 EUR
(17): Volume: 710 Unit price: 5.16 EUR
(18): Volume: 1,000 Unit price: 5.16 EUR
(19): Volume: 239 Unit price: 5.14 EUR
(20): Volume: 30 Unit price: 5.1 EUR
(21): Volume: 163 Unit price: 5.04 EUR
(22): Volume: 120 Unit price: 5.1 EUR
Aggregated transactions
(22): Volume: 10,000 Volume weighted average price: 5.16756 EUR
For further information, please contact:
Teemu Suna, CEO
ir@nightingalehealth.com, tel. +358 20 730 1810
Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670
About Nightingale
Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.